Avasopasem manganese acts as both a radioprotector and a radiomitigator of radiation-induced acute or late effects.
Saved in:
| Title: | Avasopasem manganese acts as both a radioprotector and a radiomitigator of radiation-induced acute or late effects. |
|---|---|
| Authors: | Sishc BJ; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Ramnarain D; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Shang Z; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Alves EM; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Bloom DA; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Hughes K; Department of Veterinary Medicine, Colorado State University, Ft Collins, CO, United States., Saha D; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Riley DP; Division of Molecular Radiation Biology, Department of Radiation Oncology, Galera Therapeutics, Malvern, PA, United States., Keene JL; Division of Molecular Radiation Biology, Department of Radiation Oncology, Galera Therapeutics, Malvern, PA, United States., Beardsley RA; Division of Molecular Radiation Biology, Department of Radiation Oncology, Galera Therapeutics, Malvern, PA, United States., Story MD; Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Feb 20; Vol. 16, pp. 1761003. Date of Electronic Publication: 2026 Feb 20 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1761003 |
